Holen Sie sich die Stockscreener-App
224.49
0.32%
0.72
Handel nachbörslich:
223.10
-1.39
-0.62%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DHR?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Danaher Corp Aktie (DHR) Neueste Nachrichten
Danaher Corp Lobbyists, 2022 - OpenSecrets
Danaher Corp. stock slips before the bell - AD HOC NEWS
What Does Veralto's (NYSE:VLTO) Dividend and Climate Validation Signal? - Kalkine Media
Danaher Corporation stock sets October earnings date - AD HOC NEWS
Danaher stock heads into the open after a 2.43 percent gain - AD HOC NEWS
Danaher stock ends the day 2.43 percent higher at USD 221.09 - AD HOC NEWS
Danaher Corp. stock holds near USD 200 before October results - AD HOC NEWS
Danaher (DHR) Institutional Ownership 2026 $DHR - MarketBeat
Danaher stock rises 0.16 percent ahead of the open - AD HOC NEWS
Automated Microscopy Market Advances as AI-Powered Image Analysis Transforms Digital Pathology and Semiconductor Inspection - GlobeNewswire Inc.
Danaher stock rises 2.38 percent after the close - ad-hoc-news.de
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
Danaher Schedules Third Quarter 2026 Earnings Conference Call - marketscreener.com
Danaher will webcast its next financial update Oct. 21 - Stock Titan
Danaher Corp. stock gains as valuation stays above fair value - AD HOC NEWS
Danaher Corp. stock gains 1.97 percent ahead of the open - AD HOC NEWS
Danaher stock ends the day 1.97 percent higher at the close - AD HOC NEWS
Danaher stock holds steady as reduced growth outlook tempers sentiment - AD HOC NEWS
Goldman Sachs Adjusts Price Target on Danaher to $250 From $210, Maintains Buy Rating - marketscreener.com
Danaher (DHR) Stock Forecast and Price Target 2026 $DHR - MarketBeat
Danaher stock heads into the open after a modest loss - AD HOC NEWS
Danaher Corp. stock gains after UBS starts coverage with USD 250 target - AD HOC NEWS
Danaher stock gains after UBS starts coverage at USD 250 - AD HOC NEWS
Why Is Danaher (DHR) Drawing Fresh Attention? - Kalkine Media
Cardinal Health (NYSE:CAH) Vs Danaher Corporation (NYSE:DHR) – Here’s The One Jim Cramer Said Did Better - Yahoo Finance
DHR|Danaher Corp|Price:221.090|Chg%:+5.250 - TradingKey
A new gene-editing tool is designed to reduce off-target edits - Stock Titan
Danaher (DHR) Could Be 8% Below Fair Value Following Its Dividend Reaffirmation - Yahoo Finance
Danaher Corp (DHR) Shares Surge 3.0% -- What GF Score of 80 Tells Investors - GuruFocus
Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Danaher Announces Quarterly Dividend - Yahoo Finance
Danaher Corp. stock holds near USD 200 as investors eye earnings and guidance - ad-hoc-news.de
Danaher Corp. stock underperforms Thursday when compared to competitors - MarketWatch
UBS assumes coverage on Danaher stock with buy rating, $250 target - Investing.com Nigeria
Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says - Yahoo Finance
Danaher Corp. stock gains support from UBS buy rating and July earnings beat - ad-hoc-news.de
Danaher stock heads into the open after a 0.87 percent slip - ad-hoc-news.de
Danaher Corp. stock outperforms competitors despite losses on the day - MarketWatch
Danaher stock holds near $207 after Q2 beat - ad-hoc-news.de
Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others - Yahoo Finance UK
Danaher stock heads into the open after a 0.5 percent dip - ad-hoc-news.de
Danaher Corp stock edges lower as investors weigh latest analyst targets and dividend signal - ad-hoc-news.de
Danaher (NYSE:DHR): Is Its Next Move Tied to Inflation Data? - Kalkine Media
Danaher stock holds after Q2 revenue and EPS beat - AD HOC NEWS
Danaher Corp. stock underperforms Friday when compared to competitors - MarketWatch
Danaher Corp. stock trades near 52-week highs as investors digest recent earnings - AD HOC NEWS
Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.
Danaher (DHR) Seen Deftly Navigating AI Integration - Yahoo Finance
Baird Adjusts Price Target on Danaher to $238 From $232, Keeps Outperform Rating - marketscreener.com
Danaher (DHR) Stock Trades Near Fair Value But At An Earnings Premium - Yahoo Finance
Danaher Corp. stock holds steady after recent pullback as investors weigh Q2 2026 results - AD HOC NEWS
Danaher (DHR) Stock Looks Fairly Valued On Cash Flow Yet Overvalued On Earnings - simplywall.st
A Look at Danaher Corp (DHR) After 3.1% Decline -- GF Value $242 - GuruFocus
Danaher Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Danaher Corp Stock (DHR) Moved Down by 3.06% on Sep 1: Facts Behind the Movement - TradingKey
HSBC Adjusts Price Target on Danaher to $250 From $230, Maintains Buy Rating - marketscreener.com
Danaher Corp. stock underperforms Monday when compared to competitors - MarketWatch
Is Danaher Stock Underperforming the Nasdaq? - Barchart.com
Why Danaher (DHR) Remains a Healthcare Compounder to Watch - Yahoo Finance
Danaher Rides on Strength in Biotechnology Segment: Will It Sustain? - Yahoo Finance
Danaher president & CEO Rainer Blair sells $12.7 million in company stock - Investing.com
0.50%
0.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):